Pedro MartinezPedro is a Technology Leader, former CIO/CTO and co-founder, speaker, father of 3, former paratrooper and US Army veteran.  He counts with 19 years of experience in Tech.  Follow Pedro for valuable information about Cloud adoption and overall Digital Transformation.

“You’re either part of the solution or you’re part of the problem.”


More Deaths Associated With HPV Vaccine

Posted by   


Human Papillomavirus (HPV)

Photo: Illustration of Human Papillomavirus (HPV)

By now you have probably heard many news and reports about the vaccines.  Most of those news articles are related to the political campaigns from aspiring republican candidates to the presidency of the U.S. After listening to a few of those reports, anyone with a common sense can figure out the immense amount of misinformation.  Well, it doesn’t take much to find good accurate information in regards to Human Papillomavirus (HPV) and the issues associated with the HPV vaccine.

Latest HPV Vaccine News Round Up
What is Human Papillomavirus (HPV)?
What are HPV Vaccines?
Gardasil Ingredients and its dangers
Cervarix Ingredients and its dangers
Why not to vaccinate your children w/ HPV

Latest HPV Vaccine News Round Up

US Government’s Vaccine Adverse Event Reporting System (VAERS) database contains reported instances of 23,125 adverse events [1] that include 2,952 serious cases (including death) after administering Gardasil (HPV4) vaccine. [2] Similarly, Cervarix (HPV2) vaccine reported 1,480 adverse events [3] including 322 serious cases (including death). [4] Judicial Watch, a public-interest group that has leaked countless government reports, has recently uncovered FDA documents that reveal an additional 26 deaths associated with Merck’s HPV vaccine Gardasil. [5]

At its recent board meeting in Bangladesh, the GAVI Alliance, formerly known as the Global Alliance for Vaccines and Immunizations, announced plans to bring the deadly human papillomavirus (HPV) vaccines Gardasil (Merck & Co.) and Cervarix (GlaxoSmithKline) into the third world. A pro-vaccination group backed by the World Bank, UNICEF, the Bill & Melinda Gates Foundation, and the vaccine industry, GAVI’s stated goal is to vaccinate 240 million children by 2015. [5]

In India, as many as 23,000 girls of states Andhra Pradesh and Gujarat were vaccinated under the ‘Post-licensure observational study of HPV vaccination Demonstration Project,’ carried out by an international non-governmental organization, PATH, for two American pharmaceutical companies. However, the Centre suspended the program following the death of seven girls who had been vaccinated and allegations of violation of ethics in conducting the trial. [6]

Mexico plans to administer the vaccine against human papillomavirus (HPV), which can cause cervical cancer, to all girls beginning next year, the country’s health ministry said Tuesday. Beginning in 2012, the HPV vaccine will be part of the normal course of shots given to all girls at the age of nine, Health Minister Jose Angel Cordova said. [7]

What is Human Papillomavirus (HPV)?

Human Papillomavirus (HPV) is the most common sexually transmitted virus in the United States, and many countries. It is estimated that at least 50% of sexually active people will have genital HPV at some time in their lives. [8] About 20 million Americans are currently infected, and about 6 million more get infected each year. They are called papillomaviruses because certain types may cause warts, or papillomas, which are benign (non-cancerous) growths.

HPVs are a group of more than 150 related viruses, of which more than 40 can be sexually transmitted and approximately 15 are known to cause cervical cancer. While some of these sexually transmitted HPVs are high-risk and cause cancer (known as oncogenic or carcinogenic HPVs), most others are low–risk and do not appear to cause cancer. HPV types 16 and 18 are the high-risk types that cause about 70% cases of cervical cancer. HPV types 45 and 31 are also high-risk types, causing about 5-10% of cervical cancers. HPV types 6 and 11 are low-risk (do not cause cervical cancer) and cause about 90% of genital warts.

Genital HPV infections are very common, but most occur without any symptoms and usually go away even without any treatment over the course of a few years. Sometimes, HPV infections can persist for many years. Such persistent infections with high-risk HPVs can cause cell abnormalities and have been found to be the primary cause of cervical cancer and anal cancer. HPV infections also cause some cancers of the vulva, vagina, penis, and oropharynx. [9]

Persistent HPV infections are now recognized as the cause of essentially all cervical cancers, as well as most cases of anal cancer. In 2011, more than 12,000 women in the United States are expected to be diagnosed with cervical cancer and more than 4,000 are expected to die from it. Although anal cancer is uncommon, more than 5,000 men and women in the United States are expected to be diagnosed with the disease in 2011, and more than 770 people are expected die from it. [10] Cervical cancer is diagnosed in nearly half a million women each year worldwide, claiming a quarter of a million lives annually. It has been estimated that HPV infection accounts for approximately 5 percent of all cancers worldwide.

What are HPV Vaccines?

FDA has approved two vaccines, Gardasil® and Cervarix®, which are thought to be highly effective in preventing the persistent infections commonly observed with the two HPV types that cause most cervical and anal cancers. Both vaccines protect against the two HPV types (HPV-16 and HPV-18) that cause 70% of cervical cancers, 80% of anal cancers, 60% of vaginal cancers, and 40% of vulvar cancers. [11] Gardasil and Cervarix is recommended for use in females 9 to 26 years of age. In December 2010, Gardasil was also approved for use in males 9 to 26 years of age to prevent anal cancer and associated precancerous lesions; approximately 90% of anal cancers have been linked to HPV infection. Gardasil is also considered to be effective in preventing infection with the two HPV types (HPV-6 and HPV-11) that cause most genital warts. [11] These vaccines cannot protect against established infections, nor do they protect against all HPV types. For maximum effect, it is recommended that girls and boys receive the vaccine prior to becoming sexually active.

In 2009, FDA licensed bivalent HPV vaccine (HPV2; Cervarix, GlaxoSmithKline) for use in females aged 9 through 26 years. Quadrivalent HPV vaccine (HPV4; Gardasil, Merck & Co, Inc.) was licensed in 2006 by FDA for use in females aged 9 through 26 years, and the Advisory Committee on Immunization Practices (ACIP) recommended routine HPV4 vaccination of females aged 11 or 12 years, and catch-up vaccination for females aged 13 through 26 years. Both HPV2 and HPV4 are composed of virus-like particles (VLPs) prepared from recombinant L1 capsid protein of HPV; the two vaccines are not live vaccines.

While both vaccines are available for females, only Gardasil is available for males. These vaccines are given in three shots. It is important to get all three doses to get the best protection. The vaccines are most effective when given at 11 or 12 years of age. Either vaccine is recommended for 11 and 12 year-old girls, and for females 13 through 26 years of age, who did not get any or all of the shots when they were younger. These vaccines can also be given to girls beginning at 9 years of age. It is recommended to get the same vaccine brand for all three doses, whenever possible. Gardasil is available for boys and men, 9 through 26 years of age.

Allied Healthcare Group’s investment company Coridon is developing a next generation therapeutic HPV vaccine. Coridon’s HPV vaccine has been designed to combat existing infection with the HPV virus, to prevent and treat cervical and other HPV-associated cancers. The development program will be based on preliminary work by Coridon founder Professor Ian Frazer’s team and follows on from Frazer’s work that resulted in the successful cervical cancer preventative vaccines Gardasil, marketed and Cervarix. The company’s DNA vaccine technologies differ from conventional vaccines in that they offer both preventative and therapeutic value and has the potential to be delivered with a range of adjuvants. The technology, which is covered by six granted U.S. patents, enhances protein expression in the cell or tissue targeted and results in an improved humoral response. [12]


Gardasil helps to prevent infection with four HPV types (6, 11, 16, and 18). Gardasil is given by injection and requires three doses; the first injection is followed by a second and third dose two and six months later, respectively. According to the HPV-Gardasil Vaccine Information Statements (VIS) filed with FDA, several mild to moderate problems (listed below) which do not last long and go away on their own, are known to occur with this HPV vaccine.

Reactions in the arm where the shot was given:

  • Pain (about 8 people in 10)
  • Redness or swelling (about 1 person in 4)


  • Mild (100° F) (about 1 person in 10)
  • Moderate (102° F) (about 1 person in 65)

Other problems:

  • Headache (about 1 person in 3)
  • Fainting: Brief fainting spells and related symptoms (such as jerking movements) can happen.

Gardasil Ingredients and its dangers

Gardasil is a sterile suspension for intramuscular administration. Each 0.5-mL dose contains approximately 20 mcg of HPV 6 L1 protein, 40 mcg of HPV 11 L1 protein, 40 mcg of HPV 16 L1 protein, and 20 mcg of HPV 18 L1 protein. Each 0.5-mL dose of the vaccine contains approximately 225 mcg of aluminum (as Amorphous Aluminum Hydroxyphosphate Sulfate adjuvant), 9.56 mg of sodium chloride, 0.78 mg of L-histidine, 50 mcg of polysorbate 80, 35 mcg of sodium borate, < 7 mcg yeast protein/dose, and water for injection. It does not contain preservative or antibiotics. [14]

ALUMINUM (225 mcg as Amorphous Aluminum Hydroxyphosphate Sulfate adjuvant): The United States FDA ‘Drug Labeling Regulations Guide’ states unequivocally, “Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum. Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 [micro]g/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration.” [13]

This means that for a 6 pound baby, 11-14 mcg would be toxic. Babies weigh about 12 pounds (5.5 kg) at 2 months of age when they receive 1225 mcg of aluminum from their vaccines – 50 times higher than safety levels. Currently children are getting 17 shots containing aluminum, a quadrupling of the amount given since the 1970’s. It is found in Hepatitis A, Hepatitis B, DTaP (diphtheria, tetanus, pertussis), MMR, Hib, Pneumococcal & Gardasil (HPV) vaccines. Aluminum-containing adjuvants could trigger the cascade of immunological events which are associated with autoimmune conditions including chronic fatigue syndrome and macrophagic myofasciitis. [14]

Aluminum is a coagulant which inherently binds to any toxin in its path. In fact, it’s primarily industrial use is to bond debris in water treatment centers; whereupon it is then scraped out of the cylinders during the filtration process. When aluminum gets in your blood, anything that’s toxic debris is going to bond to and coagulate and cause a toxic sludge. Within 72 hours of oxygen deprivation any cell can become cancerous. Cancer cells thrive in an oxygen-deprived environment. This will occur when bio-conductive aluminum (consisting of live virus, antibiotic, heavy metal, coagulated sludge) clogs/singes the vast network of arterial veins & capillaries leading to the brain, inducing Ischemia.

POLYSORBATE (50 mcg of Polysorbate 80): Polysorbate 80, also referred to as Tween 80 is a type of detergent stabilizer commonly found in vaccines which is linked to infertility and severe allergic reactions (anaphylaxis). Laboratory studies have found a correlation between Polysorbate 80 and ‘delayed” or stunted reproductive capacity. Polysorbate 80 was identified as the causative agent for the anaphylactoid reaction of nonimmunologic origin in the patient. Polysorbate 80 is a ubiquitously used solubilizing agent that can cause severe nonimmunologic anaphylactoid reactions. [14]

L-HISTIDINE (0.78 mg of L-histidine): L-Histidine is a diet related “essential amino acid“, also responsible for forming metal bearing enzymes (ie. metallothionein), a precursor to the allergy symptom producing hormone histamine; a synthetic form of which is added exclusively to Gardasil. ‘L-histidine supplements carry warnings that such supplements should be avoided by children, pregnant women, and nursing mothers’. Chemical composition: Chloride – 16.66-17.08%, Ammonium – ?0.02% Heavy Metals (as Pb) – ?10ppm Arsenic – ?1ppm. ‘L-histidine can pass through the placental wall to the fetus. This could be the direct cause to the spontaneous miscarriage and birth defects in some of the babies. MSDS (material safety data sheet) Section 11: Toxicological Information, Special Remarks on Chronic Effects on Humans: ‘Passes through the placental barrier in humans.’

‘In the histamine-treated sample, thrombin (blood clotting) production increased more than 5-fold from the baseline value after 30 min. After the initial time point, significantly more thrombin was formed in the histamine-activated samples.’ Whenever a vital, naturally occurring substance such as L-histidine is injected into the body subcutaneously (alongside heavy metals, live/attenuated viruses, detergents & antibiotic excipients etc) the end result, a counter effect inevitably occurs where-in the immune system cannot differentiate between the naturally occurring amino acid in the body from that present in the vaccine; registering all these intruders as a common enemy of toxic debris. The immune system instinctively kicks into overdrive, alerting any available antibodies throughout the body to identify & eliminate deposits of L-histidine it encounters in its path.

The end result, in each case, we’re seeing the antithesis of nature’s course develop, as the body, stripped of one or more primary components, is now, in essence, at war with itself. What follows is cascade of unfortunate auto-immune reactions; neurological & neuro-developmental breakdown.

SODIUM BORATE (35 mcg of sodium borate): Sodium borate, also known as borax, is ostensibly added as a “PH stabilizer” in vaccines. It is also a recognized toxic substance used in roach, rodent, and insect killers, antiseptics, some paints and enamels. ‘The National Library of Medicine (NLM) of the National Institutes of Health notes of sodium borate that it “is now known to be a dangerous poison, it is no longer commonly used in medical preparations.” That was published in 2005.

Yet the FDA in 2006 approved the Merck vaccine with this “dangerous poison” to be “commonly used” in these vaccinations. The symptoms of sodium borate poisoning according to the NLM citation include many of the side effects being reported after less than six months of the vaccine usage. These include convulsions, collapse, and seizures that include twitching of facial muscles, arms, hands, legs, and feet.’


Cervarix prevents infection with HPV types 16 and 18, and it may offer some protection against HPV types 45 and 31. Cervarix is given by injection and requires three doses; the first injection is followed by a second and third dose one and six months later, respectively. It is not clear if the vaccine is effective if fewer than three doses are given. According to the HPV-Cervarix VIS filed with FDA, several mild to moderate problems (listed below) which do not last long and go away on their own, are known to occur with this HPV vaccine.

Reactions where the shot was given:

  • Pain (about 9 people in 10)
  • Redness or swelling (about 1 person in 2)

Other mild reactions:

  • Fever of 99.5 or higher degrees Fahrenheit (about 1 person in 8)
  • Headache or fatigue (about 1 person in 2)
  • Nausea, vomiting, diarrhea, or abdominal pain (about 1 person in 4)
  • Muscle or joint pain (up to 1 person in 2)

Other problems:

  • Fainting: Brief fainting spells and related symptoms (such as jerking movements) can happen.

Cervarix Ingredients and its dangers

Cervarix is a sterile suspension for intramuscular injection. Each 0.5-mL dose is formulated to contain 20 mcg of HPV type 16 L1 protein, 20 mcg of HPV type 18 L1 protein, 50 mcg of the 3-O-desacyl-4’-monophosphoryl lipid A (MPL), and 0.5 mg of aluminum hydroxide. Each dose also contains 4.4 mg of sodium chloride and 0.624 mg of sodium dihydrogen phosphate dihydrate. Each dose may also contain residual amounts of insect cell and viral protein (<40 ng) and bacterial cell protein (<150 ng) from the manufacturing process. [23] Aluminum-containing adjuvants could trigger the cascade of immunological events which are associated with autoimmune conditions including chronic fatigue syndrome and macrophagic myofasciitis as in the case of Gardasil.

Why not to vaccinate your children w/ HPV

At the core of all medical decision making should be the following questions: When do we know enough about the beneficial effects of a new medical intervention to start recommending or using it? When is the available information about harmful adverse effects sufficient to conclude that the risks outweigh the potential benefits? If in doubt, should you err on the side of caution or on the side of hope? It is a complicated process because medical knowledge is typically incomplete and ambiguous. It is especially complex to make decisions about whether to use drugs that may prevent disease in the future, particularly when these drugs are given to otherwise healthy individuals.

Vaccines are examples of such drugs. Vaccines, by their composite nature, inherently damage and disrupt the body’s delicate neurological network; the complex functioning of the brain in maintaining all systems of operation (circulatory, digestive, endocrine, immune, lymphatic, muscular, nervous, reproductive, respiratory, skeletal, and urinary). In practical terms, a synergy factor inevitably occurs when combining multiple ingredients such as heavy metals, live viruses/or strands of DNA-RNA “heat treated virus”, antibiotics, formaldehyde, detergent, diploid cells (aborted fetal tissue), mycoplasma, phenol dye & excipient buffers together in a vial mixture. [13]

Once injected into deep muscle tissue or subcutaneously (either route which literally bypasses one’s natural barriers altogether), a cascading degeneration known as Ischemia, a singing of the neural pathways from toxic overload that prevents vital oxygen from reaching the brain, often occurs literally inhibiting normal development. The viscosity of this toxic sludge resulting from vaccines clogs / singes the vast network of arterial veins and capillaries leading to the brain while accumulating in the organs (heart, liver, kidney), joints, meninges – 3 layers of protective tissue called the dura, arachnoid, & pia mater that surround the neuraxis (axial unpaired part of the central nervous system), intestines, along the neural pathways, veins and capillaries interlacing the entire body (resulting from “stagnant” blood). Anaphylaxis, a system-wide allergic and functional breakdown, described as ‘a severe, whole-body allergic reaction to a chemical that has become an allergen‘, and Encephalitis, inflammation of the brain and meninges (Meningoencephalitis) manifesting as ‘diffuse and/or focal neuropsychological dysfunction‘, inevitably follow. [13]

The 3 doses required to complete the HPV vaccination regime are so intense, nurses administering the injections are advised to ask patients to lay down during the procedure. In many instances girls have fainted on the spot or gone into sudden seizures. Reports of Gardasil vaccine reactions filed with VAERS have reported instances of neurological symptoms including syncopal episodes and seizures, arthralgia and joint pain, Guillian-Barre Syndrome, and other immunological reactions. While all instances reported were within a week of vaccination, 63% of the initially reported reactions occurred within a day. [15]

Most commonly observed reactions were neurologic adverse events including loss of consciousness, syncope, syncopal events and seizures. Additionally, there were reports of dyskinesia (difficulty or distortion in performing voluntary movements) and hypokinesia (slow or diminished movement of the body musculature) both of which have neurological implications. Arthralgia, Joint Pain and Fever were observed in some of the reported cases. In some cases, Guillain-Barre Syndrome (GBS), which is a serious disorder in which the body’s immune system attacks part of the peripheral nervous system, was noticed. These cases were observed with individuals who were also vaccinated Aventis Pasteur’s Menactra, a vaccine for meningococcal infections. Other adverse reactions commonly found were urticaria (hives); pruritus (itching); macular and papular rashes; blisters and vesicles near the injection site; swollen arms; lymphadenopathy (swollen lymph nodes); red, hot swollen knots at injection site; burning, stabbing, severe and radiating pain at the injection site and in the affected limb during and after injection; nausea and vomiting; infections and skin ulcers, and other allergic reactions. [15]

Following these reports of adverse vaccine reactions to Gardasil, the National Vaccine Information Center raised the following concerns and questions to be addressed by government regulators, manufacturers, and physicians on Gardasil vaccine safety: [15]

  • Considering that over 20 girls have experienced syncopal episodes sometimes combined with seizures and serious injuries, physicians should consider only giving Gardasil when the patient is safely laying down on the examining table. Because there seems to be syncopal reactions up until 15 minutes after vaccination, patients should be asked to lie down for 15 minutes after receipt of Gardasil.
  • Merck does not state that it is safe to simultaneously administer Gardasil with any other vaccine. While information provided by Merck indicates that it is safe to administer Gardasil with Hepatitis B vaccine, the prescribing information only states, “Results for clinical studies indicate that Gardasil may be administered concomitantly (at a separate injection site) with hepatitis B vaccine (recombinant). Co-administration of Gardasil with other vaccines has not been studied.” Adverse reactions were reported when Gardasil was administered with eight other vaccines: Hepatitis A, MNQ, MEN (Menactra), TD (Tetanus and Diptheria Toxoids), DPP (Diptheria/Pertussis/Polio), PNC Prevnar (Heptavalent pneumococcal conjugate), DTaP (Diphtheria And Tetanus Toxoids and Acellular Pertussis Vaccine), and TDAP (Tetanus, Diptheria and Pertussis). Because Merck does not state that it is safe to administer simultaneously Gardasil with any vaccine other than Hepatitis B, consumers and clinicians should question whether co-administration of Gardasil and other vaccines is safe.

Cervical cancer is a rare disease in developed countries which invalidates the recommendations for universal immunization with any HPV vaccine. The incidence of cervical cancer has dropped substantially since implementation of regular Pap screening procedures. Currently, in the US, the death rate from cervical cancer (2.4/100,000 women) is lower than the rate of reported serious adverse events, including death, from Gardasil (3.34/100,000 doses distributed). [34]

Amid questions about the safety of the HPV vaccine Gardasil one of the lead researchers for the Merck drug is speaking out about its risks, benefits and aggressive marketing. Dr. Diane Harper says young girls and their parents should receive more complete warnings before receiving the vaccine to prevent cervical cancer. Dr. Harper helped design and carry out the Phase II and Phase III safety and effectiveness studies to get Gardasil approved, and authored many of the published, scholarly papers about it. She has been a paid speaker and consultant to Merck. It’s highly unusual for a researcher to publicly criticize a medicine or vaccine she helped get approved.

Dr. Harper joins a number of consumer watchdogs, vaccine safety advocates, and parents who question the vaccine’s risk-versus-benefit profile. She says data available for Gardasil shows that it lasts five years; there is no data showing that it remains effective beyond five years. “If we vaccinate 11 year olds and the protection doesn’t last… we’ve put them at harm from side effects, small but real, for no benefit,” says Dr. Harper. “The benefit to public health is nothing, there is no reduction in cervical cancers, they are just postponed, unless the protection lasts for at least 15 years, and over 70% of all sexually active females of all ages are vaccinated.” She also says that enough serious side effects have been reported after Gardasil use that the vaccine could prove riskier than the cervical cancer it purports to prevent. Cervical cancer is usually entirely curable when detected early through normal Pap screenings. [32]

It was observed with the HPV vaccines, especially in the case of Gardasil marketed by Merck, the messages and the methods by which the vaccine was marketed presented important challenges to physician practice and medical professionalism. By making the vaccine’s target disease cervical cancer, the sexual transmission of HPV was minimized, the threat of cervical cancer to adolescents was maximized, and the subpopulations most at risk practically ignored. The vaccine manufacturer also provided educational grants to professional medical associations (PMAs) concerned with adolescent and women’s health and oncology. The funding encouraged many PMAs to create educational programs and product-specific speakers’ bureaus to promote vaccine use. However, much of the material did not address the full complexity of the issues surrounding the vaccine and did not provide balanced recommendations on risks and benefits. [31]

The points given below should be given due consideration while deciding whether or not to vaccinate.

  • HPV virus naturally clears from the bodies of most people. Most people, who have been sexually active, have been exposed to HPV and clear the virus from their bodies within two years without any problems and are left with permanent, lifelong immunity to the HPV strains that caused infection. The small minority of women, who do not clear the HPV virus, can develop cervical cancer and die only if they do not get regular pap test screening and immediate treatment of pre-cancerous cervical lesions. [28]
  • It is to be noted that the vaccine may not provide protection against HPV in everyone who has the vaccine. It will also only provide protection against certain HPV types (16 and 18) that cause about 70% of cervical cancer, 80% of anal cancers, 60% of vaginal cancers, and 40% of vulvar cancers. Hence the vaccine is not a 100% protection against all possible infections of these cancers. It will also not protect against any other sexually-transmitted infections (STIs). This means that after having the vaccine you should still practice safe sex and use condoms to prevent commonly found HPV cancers and STIs. [25]
  • This vaccine should not be used as an alternative to having regular cervical smear tests. This is because no vaccine is 100 per cent effective and this vaccine will not provide protection against types of HPV that are not in the vaccine. It also won’t protect you from any cancerous changes that may be caused by an HPV infection you may already have. It is important to keep having regular smear tests. Routine Pap smear tests prevents cervical cancer and resulting death. After routine Pap tests became a standard part of health care for American women in the 1960’s, deaths from cervical cancer dropped by more than 70%. [25]
  • These vaccines are not recommended for girls less than ten years of age, as its safety and effectiveness have not been studied in this age group. [25]
  • The effect of giving these vaccines at the same time as other vaccines, or in combination with any other vaccines/medicines has not been properly studied or documented. [25]
  • At the moment, it is not exactly known how long the protective effect of these vaccines will last for. Clinical trials show that it provides protection for at least five years. There are no conclusive long-term studies available, and this is often cited as a reason why it does not make sense to go in for vaccination when it does not give life-long protection. [25]
  • Gardasil contains Polysorbate 80 which is linked to infertility and severe allergic reactions. Laboratory studies have found a correlation between Polysorbate 80 and ‘delayed” or stunted reproductive capacity.

Last, but not the least, there have been some concerns that the perception of safety resulting from introduction of a prophylactic HPV vaccine will lead to an increase in unsafe behaviors and premature sexual activity among adolescents (“behavioral disinhibition”). Media coverage has cited such concerns as a potential barrier to vaccine acceptance and implementation, and several small studies also have cited this as a barrier to parental and provider acceptability. Concerns about “behavioral disinhibition” are based on assumptions that perceptions of HPV risk protect adolescents from exposure to HPV and that fear of HPV is a motivation for safer sex and/or abstinence.

Dr. Diane Harper says the side effects reported so far call for more complete disclosure to patients. She says they should be told that protection from the vaccination might not last long enough to provide a cancer protection benefit, and that its risks – “small but real” – could occur more often than the cervical cancer itself would. [32]


  1. National Vaccine Information Center (NVIC). Online access to The US Government’s VAERS Data.[]=HPV4. Retrieved March 2, 2012.
  2. NVIC.[]=HPV4&SERIOUS=ON. Retrieved March 2, 2012.
  3. NVIC.[]=HPV2. Retrieved March 2, 2012.
  4. NVIC.[]=HPV2&SERIOUS=ON. Retrieved March 2, 2012.
  10. American Cancer Society (2011). Cancer Facts and Figures 2011. Atlanta, GA: American Cancer Society. Retrieved February 29, 2012.
  32. Rothman SM, Rothman DJ. Implications for Adolescent Health and Medical Professionalism. JAMA. 2009;302(7):781-786.